Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events

  Events

November 2014 Onwards
Scientific News
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
First Artificial Ribosome Designed
Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins and enzymes within the cell.
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Researchers Develop Vaccine that Protects Primates Against Ebola
A collaborative team from The University of Texas Medical Branch at Galveston and the National Institutes of Health have developed an inhalable vaccine that protects primates against Ebola.
Universal Flu Vaccine in the Works
A new study has demonstrated a potential strategy for developing a flu vaccine with potent, broad protection.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
9th Generics Asia Conference
04 Nov 2014 - 07 Nov 2014
Singapore, Asia
9th Generics Asia Conference
More information
06 Nov 2014 - 08 Nov 2014
Hyderabad, India
India Lab Expo
More information
European Antibody Congress 2014
10 Nov 2014 - 12 Nov 2014
Geneva, Switzerland
European Antibody Congress 2014
More information
World Biosimilar Congress Europe 2014
11 Nov 2014 - 12 Nov 2014
Geneva, Switzerland
World Biosimilar Congress Europe 2014
More information
Advances in Stem Cell Research (ASCR2014)
12 Nov 2014 - 13 Nov 2014
Online event
Advances in Stem Cell Research (ASCR2014)
More information
13 Nov 2014 - 16 Nov 2014
Haikou, China
BIT's 5th Annual World Gene Convention-2014  (WGC2014)
More information
17 Nov 2014 - 18 Nov 2014
London, UK
3rd Annual Cell Culture & Bioprocessing Congress 2014
More information
18 Nov 2014 - 20 Nov 2014
Istanbul, Turkey
2nd Vaccine World MENA & CIS 2014 
More information
03 Dec 2014 - 04 Dec 2014
Seoul. Korea
Vaccine World Korea 2014
More information
<< 1 2 3 4 5 6 7 >>
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!